Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Prevention of Vancomycin-Induced Nephrotoxicity
IRCT20241126063867N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in drug-induced acute kidney injury (DI-AKI), sponsored by Shahid Sadoughi University of Medical Sciences. Started Jan 2025; status: completed.
02
Drugs
melatonin
03
Conditions
drug-induced acute kidney injury (DI-AKI)
Beyond the preview
Go deeper on IRCT20241126063867N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241126063867N1.